To critically review the literature on nasal nitric oxide (nNO) and its current clinical and research applicability in the diagnosis and treatment of different sinonasal inflammatory diseases, including acute bacterial rhinosinusitis (ABRS), allergic rhinitis (AR), and chronic rhinosinusitis (CRS).
Methods:
A search of the PubMed database was conducted to include articles on nNO and sinonasal diseases from January 2003 to January 2020. All article titles and abstracts were reviewed to assess their relevance to nNO and ABRS, AR, or CRS. After selection of the manuscripts, full-text reviews were performed to synthesize current understandings of nNO and its applications to the various sinonasal inflammatory diseases.
Results:
A total of 79 relevant studies from an initial 559 articles were identified using our focused search and review criteria. nNO has been consistently shown to be decreased in ABRS and CRS, especially in cases with nasal polyps. While AR is associated with elevations in nNO, nNO levels have also been found to be lower in AR cases with higher symptom severity. The obstruction of the paranasal sinuses is speculated to be an important variable in the relationship between nNO and the sinonasal diseases. Treatment of these diseases appears to affect nNO through the reduction of inflammatory disease burden and also mitigation of sinus obstruction.
Conclusion:
nNO has been of increasing interest to researchers and clinicians over the last decade. The most compelling data for nNO as a clinical tool involve CRS. nNO can be used as a marker of ostiomeatal complex patency. Variations in measurement techniques and technology continue to impede standardized interpretation and implementation of nNO as a biomarker for sinonasal inflammatory diseases.
ColemanJW. Nitric oxide in immunity and inflammation. Int Immunopharmacol. 2001;1(8):1397-1406.
2.
ManiscalcoMBiancoAMazzarellaGMottaA. Recent advances on nitric oxide in the upper airways. Curr Med Chem. 2016;23(24):2736-2745.
3.
ChenJHTakenoSOsadaRUedaTYajinK. Modulation of ciliary activity by tumor necrosis factor-alpha in cultured sinus epithelial cells. Possible roles of nitric oxide. Hiroshima J Med Sci. 2000;49(1):49-55.
4.
KawamotoHTakenoSYajinK. Increased expression of inducible nitric oxide synthase in nasal epithelial cells in patients with allergic rhinitis. Laryngoscope. 1999;109(12):2015-2020.
5.
GiannessiFFattoriBUrsinoF, et al. Ultrastructural and ultracytochemical study of the human nasal respiratory epithelium in vasomotor rhinitis. Acta Otolaryngol. 2003;123(8):943-949.
6.
ArronJRChoyDFScheerensHMatthewsJG. Noninvasive biomarkers that predict treatment benefit from biologic therapies in asthma. Ann Am Thorac Soc. 2013;10 Suppl:S206-S213.
7.
LundbergJOFarkas-SzallasiTWeitzbergE, et al. High nitric oxide production in human paranasal sinuses. Nat Med. 1995;1(4):370-373.
8.
AlvingKWeitzbergELundbergJM. Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J. 1993;6(9):1368-1370.
9.
DweikRABoggsPBErzurumSC, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med. 2011;184(5):602-615.
WangPPWangGXGeWTTangLXZhangJNiX. Nasal nitric oxide in allergic rhinitis in children and its relationship to severity and treatment. Allergy Asthma Clin Immunol. 2017;13:20.
12.
KimH-BEckelSPKimJHGillilandFD. Exhaled NO: determinants and clinical application in children with allergic airway disease. Allergy Asthma Immunol Res. 2016;8(1):12-21.
13.
RicciardoloFLSorbelloVCiprandiG. FeNO as biomarker for asthma phenotyping and management. Allergy Asthma Proc. 2015;36(1):e1-e8.
14.
PetskyHLKewKMChangAB. Exhaled nitric oxide levels to guide treatment for children with asthma. Cochrane Database Syst Rev. 2016;2019(5):CD011439.
15.
WangZPianosiPKeoghKZaiemFAlsawasMAlahdabF, et al. Results [Internet]. The Clinical Utility of Fractional Exhaled Nitric Oxide (FeNO) in Asthma Management [Internet]. Agency for Healthcare Research and Quality (US); 2017.
16.
KouisPPapatheodorouSIYiallourosPK. Diagnostic accuracy of nasal nitric oxide for establishing diagnosis of primary ciliary dyskinesia: a meta-analysis. BMC Pulm Med. 2015;15:153.
17.
ShapiroAJJosephsonMRosenfeldM, et al. Accuracy of nasal nitric oxide measurement as a diagnostic test for primary ciliary dyskinesia. A systematic review and meta-analysis. Ann Am Thorac Soc. 2017;14(7):1184-1196.
18.
CollinsSAGoveKWalkerWLucasJS. Nasal nitric oxide screening for primary ciliary dyskinesia: systematic review and meta-analysis. Eur Respir J. 2014;44(6):1589-1599.
19.
BarbatoAFrischerTKuehniCE, et al. Primary ciliary dyskinesia: a consensus statement on diagnostic and treatment approaches in children. Eur Respir J. 2009;34(6):1264-1276.
20.
LucasJSBarbatoACollinsSA, et al. European Respiratory Society guidelines for the diagnosis of primary ciliary dyskinesia. Eur Respir J. 2017;49(1):1601090.
21.
ShapiroAJDavisSDPolineniD, et al. Diagnosis of primary ciliary dyskinesia. An official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2018;197(12):e24-e39.
22.
AmbrosinoPMolinoASpedicatoGA, et al. Nasal nitric oxide in chronic rhinosinusitis with or without nasal polyps: a systematic review with meta-analysis. J Clin Med. 2020;9(1):200.
23.
FerraroVAZanconatoSBaraldiECarraroS. Nitric oxide and biological mediators in pediatric chronic rhinosinusitis and asthma. J Clin Med. 2019;8(11):1783. doi:10.3390/jcm8111783
24.
AmbrosinoPParrellaPFormisanoR, et al. Clinical application of nasal nitric oxide measurement in allergic rhinitis: a systematic review and meta-analysis. Ann Allergy Asthma Immunol. 2020;125(4):447-459.e5. doi:10.1016/j.anai.2020.07.003
25.
WangBWuZWangFYinZShiLLiuY. Nasal nitric oxide testing for allergic rhinitis patients: systematic review and meta-analysis. Immun Inflamm Dis. 2021;9(3):635-648. doi:10.1002/iid3.439
26.
KharitonovSRajakulasingamKO’ConnorBDurhamSBarnesP. Nasal nitric oxide is increased in patients with asthma and allergic rhinitis and may be modulated by nasal glucocorticoids. J Allergy Clin Immunol. 1997;99(1 Pt 1):58-64.
27.
de Winter-de GrootKMvan der EntCK. Measurement of nasal nitric oxide: evaluation of six different sampling methods. Eur J Clin Invest. 2009;39(1):72-77.
28.
DjupeslandPGChatkinJMQianWColePZamelNMcCleanP, et al. Aerodynamic influences on nasal nitric oxide output measurements. Acta Otolaryngol. 1999;119(4):479-485.
29.
American Thoracic Society, European Respiratory Society. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med. 2005;171(8):912-930.
30.
StrubenVMDWieringaMHMantinghCJBruinsmaSMJongsteJCDFeenstraL. Silent and humming nasal NO measurements in adults aged 18–70 years. Eur J Clin Invest. 2005;35(10):653-657.
31.
ShapiroAJDellSDGastonB, et al. Nasal nitric oxide measurement in primary ciliary dyskinesia: a technical paper on standardized testing protocols. Ann Am Thorac Soc. 2020;17(2):e1-e12.
32.
Mateos-CorralDCoombsRGrasemannHRatjenFDellSD. Diagnostic value of nasal nitric oxide measured with non-velum closure techniques for children with primary ciliary dyskinesia. J Pediatr. 2011;159(3):420-424.
33.
AlexandersonCOlinA-CDahlman-HöglundAFiniziaCTorénK. Nasal nitric oxide in a random sample of adults and its relationship to sensitization, cat allergen, rhinitis, and ambient nitric oxide. Am J Rhinol Allergy. 2012;26(3):e99-e103.
34.
ShustermanDJWeaverEMGoldbergANSchickSFWongHHBalmesJR. Pilot evaluation of the nasal nitric oxide response to humming as an index of osteomeatal patency. Am J Rhinol Allergy. 2012;26(2):123-126.
35.
LundbergJOManiscalcoMSofiaMLundbladLWeitzbergE. Humming, nitric oxide, and paranasal sinus obstruction. JAMA. 2003;289(3):302-303.
36.
WeitzbergELundbergJO. Humming greatly increases nasal nitric oxide. Am J Respir Crit Care Med. 2002;166(2):144-145.
37.
ManiscalcoMSofiaMWeitzbergE, et al. Humming-induced release of nasal nitric oxide for assessment of sinus obstruction in allergic rhinitis: pilot study. Eur J Clin Invest. 2004;34(8):555-560.
38.
CristescuSMMandonJHarrenFJMeriläinenPHögmanM. Methods of NO detection in exhaled breath. J Breath Res. 2013;7(1):017104.
39.
LeighMWHazuchaMJChawlaKK, et al. Standardizing nasal nitric oxide measurement as a test for primary ciliary dyskinesia. Ann Am Thorac Soc. 2013;10(6):574-581.
40.
HouJLouHWangY, et al. Nasal ventilation is an important factor in evaluating the diagnostic value of nasal nitric oxide in allergic rhinitis. Int Forum Allergy Rhinol. 2018;8(6):686-694.
41.
AntosovaMMokraDTonhajzerovaI, et al. Nasal nitric oxide in healthy adults - reference values and affecting factors. Physiol Res. 2017;66(Suppl 2):S247-S255.
42.
GelardiMAbbattistaGQuarantaVN, et al. Standardization procedure for the nasal nitric oxide measurement method using Niox MINO® and the tidal-breathing technique with velum-closure. J Biol Regul Homeost Agents. 2016;30(3):853-858.
43.
HarrisABhullarEGoveK, et al. Validation of a portable nitric oxide analyzer for screening in primary ciliary dyskinesias. BMC Pulm Med. 2014;14(1):18.
44.
MontellaSAlvingKManiscalcoM, et al. Measurement of nasal nitric oxide by hand-held and stationary devices. Eur J Clin Invest. 2011;41(10):1063-1070.
45.
RosenfeldRMPiccirilloJFChandrasekharSS, et al. Clinical practice guideline (update): adult sinusitis. Otolaryngol Neck Surg. 2015;152(2 Suppl):S1-S39.
BaraldiEAzzolinNMBibanPZacchelloF. Effect of antibiotic therapy on nasal nitric oxide concentration in children with acute sinusitis. Am J Respir Crit Care Med. 1997;155(5):1680-1683.
48.
LanzMJPrendesSPeyrouNToledoGFerrerCM. Nasal nitric oxide as a noninvasive marker in the antibiotic treatment of acute bacterial sinusitis. J Allergy Clin Immunol. 2008;121(2):530-531.
49.
AutioTJKoskenkorvaTLeinoTKKoivunenPAlhoO-P. Longitudinal analysis of inflammatory biomarkers during acute rhinosinusitis. Laryngoscope. 2017;127(2):E55-E61.
50.
WenY-SLinC-YYangKDHungC-HChangY-JTsaiY-G. Nasal nitric oxide is a useful biomarker for acute unilateral maxillary sinusitis in pediatric allergic rhinitis: a prospective observational cohort study. World Allergy Organ J. 2019;12(4):100027.
51.
CiprandiGGalloFRicciardoloFLCirilloI. Fractional exhaled nitric oxide: a potential biomarker in allergic rhinitis?Int Arch Allergy Immunol. 2017;172(2):99-105.
52.
HenriksenAHSue-ChuMHolmenTLLanghammerABjermerL. Exhaled and nasal NO levels in allergic rhinitis: relation to sensitization, pollen season and bronchial hyperresponsiveness. Eur Respir J. 1999;13(2):301-306.
53.
LeeKJChoSHLeeSH, et al. Nasal and exhaled nitric oxide in allergic rhinitis. Clin Exp Otorhinolaryngol. 2012;5(4):228-233.
54.
OlinA-CAlvingKTorenK. Exhaled nitric oxide: relation to sensitization and respiratory symptoms. Clin Exp Allergy. 2004;34(2):221-226.
55.
ManiscalcoMSofiaMCarratùLHigenbottamT. Effect of nitric oxide inhibition on nasal airway resistance after nasal allergen challenge in allergic rhinitis. Eur J Clin Invest. 2001;31(5):462-466.
Duong-QuySVu-MinhTHua-HuyT, et al. Study of nasal exhaled nitric oxide levels in diagnosis of allergic rhinitis in subjects with and without asthma. J Asthma Allergy. 2017;10:75-82.
58.
TakenoSOkabayashiYKohnoTYumiiKHirakawaK. The role of nasal fractional exhaled nitric oxide as an objective parameter independent of nasal airflow resistance in the diagnosis of allergic rhinitis. Auris Nasus Larynx. 2017;44(4):435-441.
59.
SilkoffPEChatkinJQianW, et al. Nasal nitric oxide: a comparison of measurement techniques. Am J Rhinol. 1999;13(3):169-178.
60.
WeschtaMDeutschleTRiechelmannH. Nasal fractional exhaled nitric oxide analysis with a novel hand-held device. Rhinology. 2008;46(1):23-27.
61.
LeeJMMcKnightCLAvesTYipJGrewalASGuptaS. Nasal nitric oxide as a marker of sinus mucosal health in patients with nasal polyposis. Int Forum Allergy Rhinol. 2015;5(10):894-899.
62.
TakenoSYoshimuraHKubotaKTaruyaTIshinoTHirakawaK. Comparison of nasal nitric oxide levels between the inferior turbinate surface the middle meatus in patients with symptomatic allergic rhinitis. Allergol Int. 2014;63(3):475-483.
63.
BaraldiEAzzolinNMCarràSDarioCMarchesiniLZacchelloF. Effect of topical steroids on nasal nitric oxide production in children with perennial allergic rhinitis: a pilot study. Respir Med. 1998;92(3):558-561.
64.
Vo-Thi-KimAVan-QuangTNguyen-ThanhBDao-VanDDuong-QuyS. The effect of medical treatment on nasal exhaled nitric oxide (NO) in patients with persistent allergic rhinitis: a randomized control study. Adv Med Sci. 2020;65(1):182-188.
65.
AntosovaMBencovaAMokraDPlevkovaJPepuchaLBudayT. Exhaled and nasal nitric oxide - impact for allergic rhinitis. Physiol Res. 2020;69(Suppl 1):S123-S130.
66.
LiuCZhengMHeFWangXZhangL. Role of exhaled nasal nitric oxide in distinguishing between chronic rhinosinusitis with and without nasal polyps. Am J Rhinol Allergy. 2017;31(6):389-394.
YoshidaKTakabayashiTImotoYSakashitaMNaritaNFujiedaS. Reduced nasal nitric oxide levels in patients with eosinophilic chronic rhinosinusitis. Allergol Int. 2019;68(2):225-232.
69.
TorrettaSCappadonaMCarioliDPignataroL. Airborne nitric oxide and nasal cytology in patients with chronic rhinosinusitis and nasal polyps. J Biol Regul Homeost Agents. 2015;29(4):969-976.
70.
GilainLBeduMJouavilleLGuichardCAdvenierDMomT, et al. [Analysis of nasal and exhaled nitric oxide concentration in nasal polyposis]. Ann Otolaryngol Chir Cervicofac. 2002;119(4):234-242.
71.
ArnalJFFloresPRamiJ, et al. Nasal nitric oxide concentration in paranasal sinus inflammatory diseases. Eur Respir J. 1999;13(2):307-312.
72.
JeongJHYooHSLeeSHKimKRYoonHJKimSH. Nasal and exhaled nitric oxide in chronic rhinosinusitis with polyps. Am J Rhinol Allergy. 2014;28(1):e11-e16.
73.
FuCHHuangC-CChenY-WChangP-HLeeT-J. Nasal nitric oxide in relation to quality-of-life improvements after endoscopic sinus surgery. Am J Rhinol Allergy. 2015;29(6):e187-e191.
74.
FrendøMHåkanssonKSchwerS, et al. Exhaled and nasal nitric oxide in chronic rhinosinusitis patients with nasal polyps in primary care. Rhinology. 2018;56(1):59-64.
75.
BommaritoLGuidaGHefflerE, et al. Nasal nitric oxide concentration in suspected chronic rhinosinusitis. Ann Allergy Asthma Immunol. 2008;101(4):358-362.
76.
GuilemanyJMAngrillJAlobidI, et al. United airways again: high prevalence of rhinosinusitis and nasal polyps in bronchiectasis. Allergy. 2009;64(5):790-797.
77.
GuptaNDruschJLandisBNHummelT. Nasal nitric oxide levels do not allow for discrimination between olfactory loss due to various etiologies. Laryngoscope. 2013;123(2):311-314.
78.
HefflerEPizzimentiSBadiuI, et al. Nasal nitric oxide is a marker of poor asthma control. J Breath Res. 2013;7(2):026009.
79.
WilliamsonPAVaidyanathanSClearieKStewartMLipworthBJ. Relationship between fractional exhaled nitric oxide and nasal nitric oxide in airways disease. Ann Allergy Asthma Immunol. 2010;105(2):162-167.
80.
RimmerJHellingsPLundVJ, et al. European position paper on diagnostic tools in rhinology. Rhinology. 2019;57(Suppl S28):1-41.
81.
RagabSMLundVJSalehHAScaddingG. Nasal nitric oxide in objective evaluation of chronic rhinosinusitis therapy. Allergy. 2006;61(6):717-724.
82.
de Winter-de GrootKMvan Haren NomanSSpelemanLSchilderAGvan der EntCK. Nasal nitric oxide levels and nasal polyposis in children and adolescents with cystic fibrosis. JAMA Otolaryngol Head Neck Surg. 2013;139(9):931-936.
83.
ElsherifHSLandisBNHamadMH, et al. Olfactory function and nasal nitric oxide. Clin Otolaryngol. 2007;32(5):356-360.
